| |
Audit
|
Compensation & Benefits
|
Finance
|
Nominating & Corporate Governance
|
Public Policy
|
Science & Technology
|
|
Mary Sue Coleman, Ph.D.
(I)
|
Member
|
|
|
|
|
Member
|
President, University of Michigan
Elected 2003 Dr. Coleman was elected to the Board of Directors in 2003 and is a member of
the Audit Committee and the Science & Technology Advisory Committee. She has
served as President of the University of Michigan since August 2002, after having
served as President of the University of Iowa from 1995 to July 2002. In addition to
her current position as President, Dr. Coleman is a professor of biological chemistry
in the University of Michigan Medical School and a professor of chemistry in the
University of Michigan College of Literature, Science and the Arts. Prior to 1995,
Dr. Coleman served as Provost and Vice President for Academic Affairs at the
University of New Mexico, Vice Chancellor for Graduate Studies & Research and
Associate Provost and Dean of Research at the University of North Carolina at
Chapel Hill, and a member of the biochemistry faculty and an administrator at the
Cancer Center of the University of Kentucky in Lexington. Elected to the National
Academy of Sciences' Institute of Medicine in 1997, Dr. Coleman is a Fellow of the
American Academy of Arts and Sciences and the American Association for the
Advancement of Science. Dr. Coleman is a Director of Meredith Corporation and a
Trustee of the John S. and James L. Knight Foundation and the Gerald R. Ford
Foundation.
|
|
James G. Cullen
(I)
|
Chair
|
|
Member
|
Member
|
|
|
Retired President and Chief Operating Officer, Bell Atlantic Corporation
Bell Atlantic Corporation
Elected 1995 Mr. Cullen was elected to the Board of Directors in 1995 and is the Presiding
Director of the Board, Chairman of the Audit Committee and a member of the
Nominating & Corporate Governance Committee. Mr. Cullen retired as President
and Chief Operating Officer of Bell Atlantic Corporation (communications) in 2000.
He had assumed those positions in 1998, after having been Vice Chairman since
1995 and, prior to that, President since 1993. He was President and Chief
Executive Officer of Bell Atlantic-New Jersey, Inc. from 1989 to 1993. He is a
Director of Neustar, Inc., Prudential Financial, Inc. and Eisenhower Medical Center
and a Director and non-executive Chairman of Agilent Technologies, Inc.
|
|
Michael M.E. Johns, M.D.
(I)
|
|
Member
|
|
|
|
Member
|
Chancellor, Emory University
Elected 2005 Dr. Johns was elected to the Board of Directors in 2005 and is a member of the
Compensation & Benefits Committee and the Science & Technology Advisory
Committee. He has served since October 2007 as Chancellor of Emory University.
From 1996 to 2007, Dr. Johns served as Executive Vice President for Health Affairs
and Chief Executive Officer of the Robert W. Woodruff Health Sciences Center of
Emory University. As the Executive Vice President for Health Affairs, he oversaw
Emory University's widespread academic and clinical programs in health sciences
and led strategic planning initiatives for both patient care and research. In addition,
from 1996 to 1997, he served as the Chairman of the Board of Emory Healthcare,
the largest health care system in Georgia. From 1990 to 1996, Dr. Johns served as
Dean of the Johns Hopkins School of Medicine and Vice President of the Medical
Faculty at Johns Hopkins University. Dr. Johns is Past Chair of the Council of
Teaching Hospitals, a fellow of the American Association for the Advancement of
Science and a member of the Institute of Medicine. He is a member of the editorial
board of the Journal of the American Medical Association (JAMA) and chairs the
Publication Committee of the journal Academic Medicine. Dr. Johns is a Director of
Genuine Parts Company and AMN Healthcare Services, Inc.
|
|
Arnold G. Langbo
(I)
|
|
Chair
|
|
Member
|
|
|
Retired Chairman and Chief Executive Officer, Kellogg Company
Kellogg Company
Elected 1991 Mr. Langbo was elected to the Board of Directors in 1991 and is a member of
the Nominating & Corporate Governance Committee and Chairman of the
Compensation & Benefits Committee. Mr. Langbo retired as Chairman of
Kellogg Company (cereals and convenience foods) in 2000. He had held that
position since 1992 after having been President and Chief Operating Officer of
Kellogg since 1990. He also served as Chief Executive Officer from 1992 until 1999.
Mr. Langbo joined Kellogg Canada Inc. in 1956 and served in a number of
management positions in Canada and the United States before being named
President of Kellogg International in 1986. Mr. Langbo is a Director of Weyerhaeuser Company and Whirlpool Corporation.
|
|
Susan L. Lindquist, Ph.D.
(I)
|
|
|
|
|
Member
|
Member
|
Member and Former Director, Whitehead Institute for Biomedical Research; Professor of Biology, Massachusetts Institute of Technology
Massachusetts Institute of Technology
Elected 2004 Dr. Lindquist was elected to the Board of Directors in 2004 and is a member of
the Science & Technology Advisory Committee and the Public Policy Advisory
Committee. She is a member of the Whitehead Institute, a non-profit, independent
research and educational institution, a Professor of Biology at the Massachusetts
Institute of Technology and an Investigator of the Howard Hughes Medical Institute.
Dr. Lindquist served as Director of the Whitehead Institute from 2001 to 2004.
Previously she was affiliated with the University of Chicago where she was the
Albert D. Lasker Professor of Medical Sciences in the Department of Molecular
Genetics and Cell Biology. Dr. Lindquist was elected to the American Academy of
Arts and Sciences in 1996, the National Academy of Sciences in 1997, the
American Philosophical Society in 2003 and the Institute of Medicine in 2006.
She received the Novartis/Drew Award for Biomedical Research in 2000, the
Dickson Prize in Medicine in 2002, the Sigma Xi William Procter Prize for
Academic Achievement in 2006, the Nevada Silver Medal for Scientific
Achievement in 2007, and both the Genetics Society of America Medal and the
Centennial Medal of the Harvard University Graduate School of Arts and Sciences
in 2008. She is a member of the Science Advisory Council for the MacArthur
Foundation, the Scientific Advisory Board for the Stowers Institute for Medical
Research and the External Advisory Board of the Chicago Biomedical Consortium.
She is also a Co-Founder of FoldRx Pharmaceuticals, Inc., a private biotechnology
start-up company.
|
|
Anne M. Mulcahy
|
|
|
|
|
|
|
|
Chairman, Xerox Corporation Ms. Mulcahy was appointed to the Board of Directors in October 2009. Ms. Mulcahy was both Chairman and Chief Executive Officer of Xerox Corporation (business equipment and services) until July 2009, when she retired as CEO after eight years in the position. Prior to serving as CEO, Ms. Mulcahy was President and Chief Operating Officer of Xerox. She has also served as president of Xerox's General Markets Operations, which created and sold products for reseller, dealer and retail channels. During a career at Xerox that began in 1976, Ms. Mulcahy has also served as Vice President for Human Resources with responsibility for compensation, benefits, human resource strategy, labor relations, management development and employee training; and Vice President and Staff Officer for Customer Operations, covering South America and Central America, Europe, Asia and Africa, and China. Ms. Mulcahy is a Director of the Target Corporation, Citigroup, Inc., and The Washington Post.
|
|
Leo F. Mullin
(I)
|
Member
|
|
|
|
Chair
|
|
Retired Chairman and Chief Executive Officer, Delta Air Lines, Inc.
Delta Air Lines, Inc.
Elected 1999 Mr. Mullin was elected to the Board of Directors in 1999 and is a member of the
Audit Committee and Chairman of the Public Policy Advisory Committee. Mr. Mullin
retired as Chief Executive Officer of Delta Air Lines, Inc. (air transportation) in
December 2003 and Chairman in April 2004, after having served as Chief Executive
Officer of Delta since 1997 and Chairman since 1999.Mr.Mullin currently serves as a
Senior Advisor, on a part-time basis, to Goldman Sachs Capital Partners, a private
equity fund group. Mr. Mullin was Vice Chairman of Unicom Corporation and its
principal subsidiary, Commonwealth Edison Company, from 1995 to 1997. He was
an executive of First Chicago Corporation from 1981 to 1995, serving as that
company's President and Chief Operating Officer from 1993 to 1995, and as
Chairman and Chief Executive Officer of American National Bank, a subsidiary of
First Chicago Corporation, from 1991 to 1993.Mr.Mullin is a Director of ACE Limited
and is a member of both The Business Council and the Advisory Board of the Carter
Center. He is currently Chairman of the Board of the Juvenile Diabetes Research
Foundation (JDRF) and served as interim Chief Executive Officer of JDRF from July
through December 2008.
|
|
William D. Perez
(I)
|
|
Member
|
|
|
Member
|
|
Retired President and Chief Executive Officer, Wm. Wrigley Jr. Company
Wm. Wrigley Jr. Company
Elected 2007 Mr. Perez was elected to the Board of Directors in 2007 and is a member of the
Compensation & Benefits Committee and the Public Policy Advisory Committee.
Mr. Perez served as President and Chief Executive Officer for the Wm. Wrigley Jr.
Company (confectionary and chewing gum) from 2006 to 2008. Before joining
Wrigley, Mr. Perez served as President and Chief Executive Officer of Nike, Inc.
Previously, he spent 34 years with S.C. Johnson & Son, Inc., including eight years
as its President and Chief Executive Officer. Mr. Perez is a Director of the Campbell Soup Company and the Boys & Girls Club of Chicago and a member of the Cornell University Council.
|
|
Charles Prince
(I)
|
|
Member
|
|
Chair
|
|
|
Chairman, Sconset Group LLC; Vice Chairman and Chairman of the Board of Advisors, Stonebridge International LLC; Retired Chairman and Chief Executive Officer, Citigroup Inc.
Elected 2006 Mr. Prince was elected to the Board of Directors in 2006 and is a member of the
Compensation & Benefits Committee and Chairman of the Nominating & Corporate
Governance Committee. Mr. Prince is currently Chairman of Sconset Group, LLC
and Vice Chairman and Chairman of the Board of Advisors of Stonebridge
International LLC, a Washington, D.C. based international business strategy firm,
which he joined in September 2008. Mr. Prince served as Chief Executive Officer of
Citigroup Inc. (financial services) from 2003 to 2007 and as Chairman from 2006 to
2007. Previously he served as Chairman and Chief Executive Officer of Citigroup's
Global Corporate and Investment Bank from 2002 to 2003, Chief Operating Officer
from 2001 to 2002, and Chief Administrative Officer from 2000 to 2001. Mr. Prince
began his career as an attorney at U.S. Steel Corporation in 1975, and in 1979 joined
Commercial Credit Company (a predecessor company to Citigroup) where he held
various management positions until 1995, when he was named Executive Vice
President. Mr. Prince is a Director of Xerox Corporation and a member of the Council
on Foreign Relations and The Business Council. He is also on the Board of Trustees
of the Brookings Institution.
|
|
David Satcher, M.D., Ph.D.
(I)
|
|
|
|
|
Member
|
Chair
|
Director, Center of Excellence on Health Disparities, Director, Satcher Health Leadership Institute and Poussaint-Satcher-Cosby Chair in Mental Health, Morehouse School of Medicine
Morehouse School of Medicine
Elected 2002 Dr. Satcher was elected to the Board of Directors in 2002 and is Chairman of
the Science & Technology Advisory Committee and a member of the Public Policy
Advisory Committee. Dr. Satcher assumed his current post at Morehouse School of
Medicine in 2004 and served as the School's Interim President from 2004 until 2006
and Director of the School's National Center for Primary Care from 2002 through
2004. In 2002, Dr. Satcher completed his four-year term as the 16th Surgeon
General of the United States. He also served as the U.S. Assistant Secretary for
Health from 1998 to 2001. From 1993 to 1998, Dr. Satcher served as Director of the
Centers for Disease Control and Prevention and Administrator of the Agency for
Toxic Substances and Disease Registry. Dr. Satcher served as President of
Meharry Medical College in Nashville, Tennessee, from 1982 to 1993.
Dr. Satcher is a fellow of the American Academy of Family Physicians, the
American College of Preventive Medicine and the American College of
Physicians. He has received numerous honorary degrees and awards, including
the Jimmy and Rosalynn Carter Award for Humanitarian Contributions to the Health
of Humankind, the New York Academy of Medicine Lifetime Achievement Award
and the National Association of Mental Illness Distinguished Service Award.
Dr. Satcher is a Director of MetLife, Inc., and serves on the boards of Action for
Healthy Kids, American Foundation for Suicide Prevention, Kaiser Family
Foundation and Task Force for Child Survival and Development.
|
|
William C. Weldon
(C)
|
|
|
Chair
|
|
|
|
Chairman, Board of Directors and Chief Executive Officer, Chairman, Executive Committee
Johnson & Johnson
Elected 2001 Mr.Weldon was elected to the Board of Directors and named Vice Chairman of
the Board in 2001 and assumed his current responsibilities in 2002. Mr. Weldon
joined the Company in 1971, and served in several sales, marketing and
international management positions before becoming President of Ethicon
Endo-Surgery in 1992 and Company Group Chairman of Ethicon Endo-Surgery
in 1995. He was appointed to the Executive Committee and named Worldwide
Chairman, Pharmaceuticals Group, in 1998. Mr. Weldon is also a Director of J.P.
Morgan Chase & Co. Mr. Weldon is a member of The Business Council and the
Sullivan Alliance to Transform America's Health Profession. He is a Trustee of
Quinnipiac University and serves on the Liberty Science Center Chairman's
Advisory Council. Mr. Weldon also serves as Chairman of the CEO Roundtable
on Cancer.
|
Stock transaction information provided by EDGAR Online. Johnson & Johnson makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.